4//SEC Filing
Froimson Mark 4
Accession 0001396814-25-000085
CIK 0001396814other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:18 PM ET
Size
7.4 KB
Accession
0001396814-25-000085
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Award
Common Stock
2025-06-11+6,163→ 20,636 total - Award
Stock Option (Right to Buy)
2025-06-11+11,279→ 11,279 totalExercise: $24.34From: 2026-06-11Exp: 2035-06-11→ Common Stock (11,279 underlying)
Footnotes (2)
- [F1]Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001709050
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:18 PM ET
- Size
- 7.4 KB